Cybin to acquire Small Pharma creating an international clinical-stage leader in novel psychedelic therapeutics.
Financial highlights and recent business and R&D highlights.
Multiple clinical milestones achieved with operational efficiencies underway.
Small Pharma to participate in Jefferies Conference and CNS Summit.
Second quarter 2023 highlights including last patient dosed.
The ASPP has been approved by the TSX Venture Exchange.
The TSX Venture Exchange has accepted Small Pharma's application.
Progress continues with multiple trials expected to enter clinic later this year.
Small Pharma reports highlights for the fiscal year ended February 2022.
Small Pharma shares business update ahead of annual financial results, including a new COO appointment.